Gara Jalqabaatti › Myelodysplastic Syndromes › New Jersey › Edison
Qorannoo klinikaalii Myelodysplastic Syndromes Edison, NJ keessatti
Qorannoo 7 Myelodysplastic Syndromes f Edison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Namoota walitti qabaa jiraSadarkaa 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Namoota walitti qabaa jiraSadarkaa 1/2
- START New Jersey, East Brunswick · Miili 6 fagaatti
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Saint Peter's University Hospital, New Brunswick · Miili 3 fagaatti
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · Miili 3 fagaatti
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, New Brunswick · Miili 3 fagaatti
Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti
- Houston, TXQorannoo 43
- Baldwin Park, CAQorannoo 26
- Seattle, WAQorannoo 21
- New York City, NYQorannoo 21
- Washington, DCQorannoo 20
- Boston, MAQorannoo 19
- Tampa, FLQorannoo 19
- Miami, FLQorannoo 17
- Columbus, OHQorannoo 14
- Durham, NCQorannoo 14
- Atlanta, GAQorannoo 13
- Chicago, ILQorannoo 13
Qorannoo biroo Edison keessatti
- Saree OljooQorannoo 68
- Kansara Qara'a Non-Small CellQorannoo 47
- Saree (Gosoota Hunda)Qorannoo 33
- Kansarii ProstateQorannoo 29
- Kansarii ColorectalQorannoo 23
- Dhibee QaraQorannoo 23
- Myeloma Baay’eeQorannoo 22
- Dukkana BladderQorannoo 21
- Kansara MetastatikiiQorannoo 20
- Kansarii OvariiQorannoo 20
- Leukemia Myeloidii HamaaQorannoo 20
- Kansa EndometiriyaaliiQorannoo 19
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.